Ferring, Blackstone to invest $570m in gene therapy for bladder cancer

Ferring Pharmaceuticals and Blackstone Life Sciences to invest over $570m in nadofaragene firadenovec. Photo: courtesy of Gerd Altmann from Pixabay.